Blood Cancer United (Formerly Reported Asthe Leukemia and Lymphoma Society)

Non profit dedicated to funding blood cancer research.

Based in DC

🤖

AI Overview

With $1.8M in lobbying spend across 35 quarterly filings, Blood Cancer United (Formerly Reported Asthe Leukemia and Lymphoma Society) is a significant lobbying presence. Their lobbying covers 5 issue areas. Active from 2018 to 2025.

$1.8M
Total Spend
8
Years Active
1
Firms Hired
7
Lobbyists Deployed
5
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$200K
2019$350K
2020$200K
2021$200K
2022$200K
2023$200K
2024$220K
2025$240K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Pharmacy, Budget/Appropriations, Health Issues, Taxation

  • Issues related to Medicare Part D as related to blood cancer beneficiaries.
  • Issues related to the cost of care and protecting patient access to blood cancer treatment. Issues related to specialty drug tiers.
  • Issues related to blood cancer research funding included in H. R. 1625, the Consolidated Appropriations Act of 2018.
  • Issues related to blood cancer research, diagnosis, treatment and cures including coverage and reimbursement of cancer treatment therapies and issues related to H. R.1409 the Cancer Drug Parity Act of

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.